Finance

Lists
4549:TYO
Eiken Chemical Co Ltd
Â¥2,239.00
+0.04%
(+1.00) 1D
Nov 4, 10:01:47 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4549...
Open
Â¥2,238
High
Â¥2,250
Low
Â¥2,201
Mkt. cap
77.34B
Avg. vol.
139.95K
Volume
14.60K
Dividend
2.59%
Quarterly dividend
Â¥15
Ex-dividend date
Sep 29, 2026
P/E ratio
39.92
52-wk high
Â¥3,500
52-wk low
Â¥2,021
EPS
Â¥56
Shares outstanding
36.88M
No. of employees
696
Open
Â¥2,238
High
Â¥2,250
Low
Â¥2,201
Mkt. cap
77.34B
Avg. vol.
139.95K
Volume
14.60K
Dividend
2.59%
Quarterly dividend
Â¥15
Ex-dividend date
Sep 29, 2026
P/E ratio
39.92
52-wk high
Â¥3,500
52-wk low
Â¥2,021
EPS
Â¥56
Shares outstanding
36.88M
No. of employees
696
News stories
From web sources and news partners
Profile
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment. Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products. The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, and an alternative to traditional PCR. Wikipedia
About Eiken Chemical Co Ltd
CEOMorifumi Wada
Employees696
FoundedFeb 20, 1939
Headquarters-
SectorMedical device
Industry-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
10.95B
10.52B
10.69B
10.69B
Cost of goods sold
6.70B
6.97B
6.65B
6.65B
Cost of revenue
6.70B
6.97B
6.65B
6.65B
Research and development expenses
-
3.68B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.20B
-262.00M
3.25B
3.25B
Operating expense
3.20B
3.41B
3.25B
3.25B
Total operating expenses
9.90B
10.38B
9.90B
9.90B
Operating income
1.05B
141.00M
794.00M
794.00M
Other non operating income
-54.00M
19.00M
48.00M
48.00M
EBT including unusual items
1.00B
102.00M
808.50M
808.50M
EBT excluding unusual items
995.00M
-1.89B
808.00M
808.00M
Income tax expense
260.00M
116.00M
246.00M
246.00M
Effective tax rate
25.92%
113.73%
30.43%
30.43%
Other operating expenses
-
-
-
-
Net income
743.00M
-14.00M
562.50M
562.50M
Net profit margin
6.79%
-0.13%
5.26%
5.26%
Earnings per share
-
-
-
-
Interest and investment income
4.00M
5.00M
12.00M
12.00M
Interest expense
-5.00M
-15.00M
-19.50M
-19.50M
Net interest expenses
-1.00M
-10.00M
-7.50M
-7.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.62B
775.00M
1.43B
1.43B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps